70CMSD23FR0000217↗

Name: 70CMSD23FR0000217: Naloxone Internasal Spray in Support of National Fentanyl Operations
Creator: SpendQuery

NALOXONE INTERNASAL SPRAY IN SUPPORT OF NATIONAL FENTANYL OPERATIONS

Delivery Order · U.S. Immigration and Customs Enforcement · to Emergent Devices, Inc. (UEI Q1MZNNSQUJ53) · data as of 2026-09-30

Obligated to date$19.9K2 actions

Current value$19.9Kwith options exercised

Period2023-09-15 → 2023-10-15current end date

What it is

Product or service: Drugs and Biologicals (PSC 6505)
Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)
Contracting office: Investigations and Operations Support Dallas (70CMSD)
Competition: Full and open competition · 1 offer received
Pricing: Firm fixed price
How it was bought: GSA Schedule · under 36F79723D0188
Where the work is: San Diego, CA · district CA-51
Topics: opioids

Obligations by fiscal year

FY2023$19.9K

FY2025$0

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2023-09-15. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2025-02-11	P00001	Close-out	$0	NALOXONE INTERNASAL SPRAY IN SUPPORT OF NATIONAL FENTANYL OPERATIONS
2023-09-15	0		$19.9K	NALOXONE INTERNASAL SPRAY IN SUPPORT OF NATIONAL FENTANYL OPERATIONS

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗